Market Overview

BioMed Realty Trust Announces Tax Treatment Of 2012 Distributions

SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2012 distributions as follows:

Security Description: Common Stock

CUSIP: 09063H107

Ticker Symbol: BMR

Record Date

Payable Date

Total Distribution

Per Share

Allocable to 2012

Taxable Ordinary Dividend

 

Return of Capital

Long-Term Capital Gain

Unrecaptured Section 1250 Gain

12/30/2011

1/17/2012

$0.200000

$0.200000

$0.148244

$0.051756

$0.000000

$0.000000

3/30/2012

4/16/2012

$0.215000

$0.215000

$0.159362

$0.055638

$0.000000

$0.000000

6/29/2012

7/16/2012

$0.215000

$0.215000

$0.159362

$0.055638

$0.000000

$0.000000

9/28/2012

10/15/2012

$0.215000

$0.215000

$0.159362

$0.055638

$0.000000

$0.000000

Totals

$0.845000

$0.845000

$0.626330

$0.218670

$0.000000

$0.000000

Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock

CUSIP: 09063H206

Ticker Symbol: BMR PR A

Record Date

Payable Date

Total Distribution

Per Share

Allocable to 2012

Taxable Ordinary Dividend

 

Return of Capital

Long-Term Capital Gain

Unrecaptured Section 1250 Gain

12/30/2011

1/17/2012

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000

3/30/2012

4/16/2012

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000

6/29/2012

7/16/2012

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000

9/28/2012

10/15/2012

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000

Totals

$1.843760

$1.843760

$1.843760

$0.000000

$0.000000

$0.000000

The distributions payable on January 15, 2013 to shareholders of record on December 31, 2012, as previously declared on December 12, 2012, are considered 2013 distributions for federal income tax purposes.

Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research.  Additional information is available at www.biomedrealty.com.

SOURCE BioMed Realty Trust, Inc.

 

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free